University of the District of Columbia
4200 Connecticut Avenue, NW, Washington, DC 20008
Lombardi Comprehensive Cancer Center at Georgetown University
3800 Reservoir Road, NW, Washington, DC 20057
Deepak Kumar, PhD
Associate Professor, Department of Biological and Environmental Sciences,
Bldg 44, Rm 312, University of the District of Columbia,
Washington DC 20008
Tel: (202) 274-5937
Fax: (202) 274-5776
Email: dkumar@udc.edu

  Selected Publications (Since 2004)
  
   1.  Verma M. and  Kumar, D., Diagnosing Cancer Using Histone Modification Analysis. 2007 in Cancer Epigenetics, CRC Press (In Press)
   2. Chauhan S.C., Jaggi, M., Bell, M., Verma, M and Kumar, D. Epidemiology of Human Papillomavirus (HPV) in cervical mucosa. 2007, in Cancer  
   Epidemiology, Ed. M. Verma, Humana Press (In Press)
   3. Kumar, D and Verma, M. Methods in Cancer Epigenetics and Cancer Epidemiology. 2007 in Cancer Epidemiology, Ed. M. Verma, Humana Press (In
   Press)
   4. Verma, M. and Kumar, D. Application of mitochondrial genome information in cancer epidemiology. Clin Chim Acta. 2007, 383: 41-50
   5. Verma, M., Naviaux R., Tanaka, M., Kumar, D., Franceschi C., and Singh, K. Mitochondrial DNA and Cancer Epidemiology. Cancer Res. 2007 67:
   437-439
   6. Chauhan S.C., Kumar D., Bell, M., Koch, R. and Verma M. Molecular Markers of Miscellaneous Primary and metastatic Tumors of the Uterine Cervix. Eur.     J.
  Gyn. Onc.2007. XXVIII: 5-14
   7. Liang L., Mandal V., Lu, Yi and Kumar, D. Multi-dimensional Cluster Misclassification Test for Pathway Differential Analysis of Diabetes. 2007,
   Proceedings of the First International Multi-Symposiums on Computer and Computational Sciences (IMSCCS). University of Iowa. IA.
   8. Boudreau, H.E., Broustas, C.G., Gokhale, P.C., Kumar, D., Mewani, R., Rone J.D., Haddad, B.R., Ahmad, I and Kasid U.  Expression of BRCC3, a novel
   cell cycle regulated molecule, is associated with increased phosphor-ERK and cell proliferation. Int. J. Mol. Med, 2007, 19: 29.
   9. Kumar D and Verma M. Molecular markers of cervical squamous cell carcinoma. CME Journal of Gynecologic Oncology 2006; 11: 41-60.
  10. Zhang C, Pei J, Kumar D, Sakabe I, Boudreau HE, Gokhale PC, Kasid U.  Antisense Oligonucleotides: Target Validation and Development of
  Systemically-Delivered Therapeutic Nanoparticles. Methods Mol. Biol., 2006, 361: 163-186
  11. Liang, L.R., Lu S., Wang, X., Lu, Y., Mandal, V., Patacsil, D and Kumar D. A Fuzzy-Set-Theory-Based Approach to Differential Gene Expression Data
  Analysis. BMC J. Bioinformatics 2006, 7 (Suppl 4): S7
  12. Srivastava, R., Kumar, D., Waskar, M.N., Sharma, M., Katoch, V.M. and Srivastava, B.S. Identification of a repetitive sequence belonging to a PPE gene of
  Mycobacterium tuberculosis and its use in diagnosis of tuberculosis.  J. Mol. Microbiol., 2006, 55:1071
  13. Tian, S., Mewani, R., Kumar, D., Li, B., Danner, M., Ahmad, I., Rahman A., Notario, V., Dritschilo, A., Kasid, U.N., and Gokhale, P.C., Phosphorylation
  and stabilization of X-linked inhibitor of apoptosis (XIAP) by Raf-1 kinase. Int. J. Oncol, 2006, 29: 861-867
  14. Lu, Y., Lu, S., Liang, L. and Kumar D. FM-test: A Fuzzy Set Theory Based Approach for the Identification of Diabetes Genes.  IEEE Symposium of
  Computations in Bioinformatics and Bioscience, pp.48-55, Hangzhou, Zhejiang, China, June, 2006.
  15. Liang L., Lu, S., Lu, Y., Dhawan P. and Kumar D. CM-test: An innovative divergence measurement and its application in diabetes gene expression data   
  analysis. IEEE International Conference on Granular Computing, Atlanta, GA, USA, pp.262-268, 2006.
  16. Dritschillo A., Huang C.H., Rudin C., Marshall J., Collins B., Steinberg J., Wanaski S., Dul J., Sherman J., Zhang C., Kumar D., Gokhale PC., Ahmad A.,
  Ahmad I. and Kasid U., Phase I study of liposome-encapsulated c-raf Antisense Oligodeoxyribonucleotide (LErafAON) infusion during radiation therapy in
  patients with advanced malignancies. Clin. Cancer Res, 2006 12:1251-9)
  17. Zhang C, Chakravarty D, Sakabe I, Mewani RR, Boudreau HE, Kumar D, Ahmad I, Kasid UN. Role of SCC-S2 in Experimental Metastasis and Modulation
  of VEGFR-2, MMP-1, and MMP-9 Expression. Mol Ther. 2006, 13:947-55.
  18. Rudin C.M., Marshall J., Huang C.H., Kindler H.L., Zhang C., Kumar D., Gokhale P., Kasid U. and Ratain M.J., Delivery of a liposome c-raf-1 antisense
  oligonucleotide by weekly bolus dosing in patients with advanced solid tumors: a phase I study. Clin.Cancer. Res, 2004, 10:7244-7251.
  19. Kumar D., Patel S., Whiteside TL and Kasid U. SCC-112 is a novel gene inducing apoptosis and a candidate tumor suppressor gene in human breast
  cancer and renal cell carcinoma. Gene 2004 328: 187-196.
  20. Kumar D., Gokhale P., Broustas C., Chakravarty D., Ahmad I., Whiteside T.L., Kasid U. Over expression of SCC-S2 leads to increased cell growth and
  tumorigenicity in MDA-MB 435 breast cancer cells Oncogene, 2004 23: 612-616